Curran KJ, Margossian SP, Kernan NA, et al. Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL. Blood. 2019;134(26):2361-2368.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555408/
https://www.ncbi.nlm.nih.gov/pubmed/32957119
http://dx.doi.org/10.1182/blood.2020008394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555408/
https://www.ncbi.nlm.nih.gov/pubmed/32957119
http://dx.doi.org/10.1182/blood.2020008394

Ejemplares similares